Acute myocardial infarction risk in multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study in South Korea

Abstract

Background:

The link between neuromyelitis optica spectrum disorder (NMOSD) and cardiovascular disease is currently unclear.

Objective:

To determine the acute myocardial infarction (MI) risk in patients with MS and NMOSD.

Methods:

This study analyzed the Korean National Health Insurance Service database between January 2010 and December 2017. The included patients comprised 1503/1675 adults with MS/NMOSD who had not experienced ischemic heart disease or ischemic stroke at the index date. Matched controls were selected based on age, sex, and the presence of hypertension, diabetes mellitus (DM), and dyslipidemia.

Results:

The risks of developing MI were 2.61 (hazard ratio (HR), 95% confidence interval (CI) 1.73–3.95) and 1.95 (95% CI = 1.18–3.22) times higher in MS and NMOSD compared with the control populations. Patients with NMOSD had a similar MI risk compared with patients with MS, after adjusting for age, sex, income, hypertension, DM, and dyslipidemia (HR = 0.59, 95% CI = 0.34–1.02, p = 0.059). Among each patient group, the MI risk did not differ significantly with age (20–39, 40–64 or ⩾65 years), sex, or the presence of hypertension, DM, or dyslipidemia.

Conclusion:

The MI risk increased in MS and NMOSD and seemed to be comparable between NMOSD and MS.

Keywords

Multiple sclerosis neuromyelitis optica spectrum disorder myocardial infarction risk Asia

Get full access to this article

View all access options for this article.

References

Brønnum-Hansen

Koch-Henriksen

Stenager

. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 2004; 127(Pt 4): 844–850.

Marrie

Elliott

Marriott

, et al. Effect of comorbidity on mortality in multiple sclerosis. Neurology 2015; 85: 240–247.

Zhang

Tremlett

Zhu

, et al. Effects of physical comorbidities on disability progression in multiple sclerosis. Neurology 2018; 90: e419–e427.

Kowalec

McKay

Patten

, et al. Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study. Neurology 2017; 89: 2455–2461.

Persson

Lee

Yood

, et al. Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study. Mult Scler Relat Disord 2020; 37: 101423.

Palladino

Marrie

Majeed

, et al. Evaluating the risk of macrovascular events and mortality among people with multiple sclerosis in England. JAMA Neurology 2020; 77: 820–828.

Marrie

Garland

Schaffer

, et al. Traditional risk factors may not explain increased incidence of myocardial infarction in MS. Neurology 2019; 92: e1624–e1633.

Christiansen

Christensen

Farkas

, et al. Risk of arterial cardiovascular diseases in patients with multiple sclerosis: A population-based cohort study. Neuroepidemiology 2010; 35(4): 267–274.

Castelo-Branco

Chiesa

Bengtsson

, et al. Non-infectious comorbidity in patients with multiple sclerosis: A national cohort study in Sweden. Mult Scler J Exp Transl Clin 2020; 6(3): 2055217320947761.

10.

Thormann

Magyari

Koch-Henriksen

, et al. Vascular comorbidities in multiple sclerosis: A nationwide study from Denmark. J Neurol 2016; 263(12): 2484–2493.

11.

Chou

Kuo

Tanasescu

, et al. Comorbidity in multiple sclerosis: Its temporal relationships with disease onset and dose effect on mortality. Eur J Neurol 2020; 27(1): 105–112.

12.

Jadidi

Mohammadi

Moradi

. High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Mult Scler 2013; 19(10): 1336–1340.

13.

Papp

Magyari

Aktas

, et al. Worldwide incidence and prevalence of neuromyelitis optica: A systematic review. Neurology 2021; 96: 59–77.

14.

Kim

Park

S-H

Han

, et al. Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea. Mult Scler 2020; 26(14): 1837–1844.

15.

Shin

Cho

Guallar

. Korean national health insurance database. JAMA Intern Med 2016; 176: 138.

16.

Song

Jung

Song

, et al. Background and data configuration process of a nationwide population-based study using the Korean national health insurance system. Diabetes Metab J 2014; 38(5): 395–403.

17.

Polman

Reingold

Edan

, et al. Diagnostic criteria for multiple sclerosis: 2005 Revisions to the “McDonald criteria.” Ann Neurol 2005; 58(6): 840–846.

18.

Wingerchuk

Lennon

Pittock

, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485–1489.

19.

Wingerchuk

Banwell

Bennett

, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85: 177–189.

20.

Libby

. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 2013; 368: 2004–2013.

21.

Marrie

Reider

Cohen

, et al. A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis. Mult Scler 2015; 21(3): 318–331.

22.

Marrie

Fisk

Tremlett

, et al. Differing trends in the incidence of vascular comorbidity in MS and the general population. Neurology: Clinical Practice 2016; 6: 120–128.

23.

Gimbrone

Jr García-Cardeña

. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circulation Research 2016; 118: 620–636.

24.

Escárcega

Lipinski

Garcia-Carrasco

, et al. Inflammation and atherosclerosis: Cardiovascular evaluation in patients with autoimmune diseases. Autoimmun Rev 2018; 17(7): 703–708.

25.

Ohl

Tenbrock

Kipp

. Oxidative stress in multiple sclerosis: Central and peripheral mode of action. Exp Neurol 2016; 277: 58–67.

26.

Dubchenko

Ivanov

Spirina

, et al. Hyperhomocysteinemia and endothelial dysfunction in multiple sclerosis. Brain Sciences 2020; 10: 637.

27.

Kim

Han

, et al. Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: A nationwide population-based study. BMC Public Health 2019; 19: 1–11.

28.

Ajmera

Boscoe

Mauskopf

, et al. Evaluation of comorbidities and health care resource use among patients with highly active neuromyelitis optica. J Neurol Sci 2018; 384: 96–103.

29.

Wang

, et al. Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica. Mult Scler 2013; 19(7): 926–931.

30.

Millett

Peters

Woodward

. Sex differences in risk factors for myocardial infarction: Cohort study of UK Biobank participants. BMJ 2018; 363: k4247.

31.

Bairey Merz

Shaw

Reis

, et al. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part II: Gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 2006; 47: S21–S29.

32.

Tremlett

Zhao

Joseph

, et al. Relapses in multiple sclerosis are age-and time-dependent. J Neurol Neurosurg Psychiatry 2008; 79(12): 1368–1374.

33.

Kermode

, et al. Risk of relapse in patients with neuromyelitis optica spectrum disorder: Recognition and preventive strategy. Mult Scler Relat Disord 2020; 46: 102522.

34.

Senzaki

Okada

Ochi

, et al. Vascular endothelial dysfunction associated with severity in multiple sclerosis. Mult Scler Relat Disord 2021; 54: 103135.

35.

Akil

Alp

Aluclu

, et al. Serum endocan levels in multiple sclerosis relapse and remission. Eur Rev Med Pharmacol Sci 2021; 25(11): 4091–4098.

36.

OECD. Alcohol consumption (indicator), https://doi.org/10.1787/e6895909-en (accessed 2 July 2019).

37.

OECD. Daily smokers (indicator), https://doi.org/10.1787/1ff488c2-en (accessed 2 July 2019).

38.

OECD. Overweight or obese population (indicator), https://doi.org/10.1787/86583552-en (accessed 2 July 2019).

39.

Romba

Newsome

McArthur

. Acute myocardial infarction associated with initial alemtuzumab infusion cycle in relapsing-remitting multiple sclerosis. Mult Scler Relat Disord 2019; 34: 100–102.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB